Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Di-Tan Decoction is a traditional Chinese medicine (TCM) formula developed in 1449 by the physician Dong Su. It is composed of nine herbal ingredients, with Arisaema (Tian Nan Xing) and Red Tangerine Peel (Ju Hong) as principal components. The formula belongs to the category of TCM formulas that dispel phlegm and is traditionally used to "resolve phlegm to open the orifices." In modern clinical practice, it has been used for conditions such as Alzheimer's disease and post-stroke neurological disorders including dysphagia. Its main actions are removing phlegm and opening sensory orifices according to TCM theory. Western medical research has explored its use in treating cognitive symptoms associated with Alzheimer's disease and improving swallowing function after stroke[1][4][5]. The mechanism of action from a biomedical perspective remains unclear but may involve neuroprotective effects or modulation of neurotransmitter systems.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on di-tan decoction.